Obstet Gynecol Sci.  2017 Sep;60(5):485-489. 10.5468/ogs.2017.60.5.485.

Estrogen-induced acute pancreatitis: A case report and literature review

• Seo D
• Suh H
• Lee JK
• Jang DK
• Kwon HY
• Lee CH
• Yoon SH
• Roh JW
• Park HS

• KMID: 2393851
• DOI: http://doi.org/10.5468/ogs.2017.60.5.485

Abstract

Estrogens are commonly used in gynecologic area, such as oral contraception, hormone replacement therapy, and in vitro fertilization-embryo transfer. Although estrogen is a common cause of acute drug-induced pancreatitis, there has been paucity of report in Korea. Clinical course of estrogen-induced acute pancreatitis is usually mild to moderate, but fetal case can occur. In addition, there can be a latency from the first administration to the symptom. Therefore, physicians should consider the possibility of the disease when a woman taking estrogen or previous history of taking estrogen presents with acute abdominal pain. Here, we report a case of estrogen-induced acute pancreatitis that occurred during the preparation for embryo transfer.

Keyword

Acute pancreatitis; Drug-induced acute pancreatitis; Estrogen

MeSH Terms

Abdominal Pain
Contraception
Embryo Transfer
Estrogens
Female
Hormone Replacement Therapy
Humans
In Vitro Techniques
Korea
Pancreatitis*
Estrogens

Figure

• 

  Fig. 1 (A) Mild swelling of pancreas head (arrow) with peripancreatic infiltration, the presence of peripancreatic fluid (arrow head) and fluid in the upper mesentery (admission day). (B) Increased of peripancreatic fluid collection (arrow head) (4th hospital day). (C) Decreased peripancreatic fluid collection (2 months after discharge).

Reference

1. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007; 5:648–661.

2. Abraham M, Mitchell J, Simsovits D, Gasperino J. Hypertriglyceridemic pancreatitis caused by the oral contraceptive agent estrostep. J Intensive Care Med. 2015; 30:303–307.

3. Lee J, Goldberg IJ. Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction. J Clin Lipidol. 2008; 2:63–66.

4. Oskarsson V, Orsini N, Sadr-Azodi O, Wolk A. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study. CMAJ. 2014; 186:338–344.

5. Perego E, Scaini A, Romano F, Franciosi C, Uggeri F. Estrogen-induced severe acute pancreatitis in a male. JOP. 2004; 5:353–356.

6. Gan SI, Edwards AL, Symonds CJ, Beck PL. Hypertriglyceridemia-induced pancreatitis: a case-based review. World J Gastroenterol. 2006; 12:7197–7202.

7. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003; 36:54–62.

8. Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010; 24:143–155.

9. Vrablik M, Fait T, Kovar J, Poledne R, Ceska R. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Metabolism. 2008; 57:1088–1092.

10. Davar R, Janati S, Mohseni F, Khabazkhoob M, Asgari S. A comparison of the effects of transdermal estradiol and estradiol valerate on endometrial receptivity in frozen-thawed embryo transfer cycles: a randomized clinical trial. J Reprod Infertil. 2016; 17:97–103.

11. Madero S, Rodriguez A, Vassena R, Vernaeve V. Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer. Hum Reprod. 2016; 31:1755–1764.

12. Dal Prato L, Borini A, Cattoli M, Bonu MA, Sciajno R, Flamigni C. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril. 2002; 77:956–960.

13. Bank S, Marks IN. Case reports. Hyperlipaemic pancreatitis and the pill. Postgrad Med J. 1970; 46:576–578.

14. Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med. 1973; 289:552–555.

15. Ruman J, Brenner S, Sauer MV. Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer. J Assist Reprod Genet. 2002; 19:94–97.